000 | 01673 a2200493 4500 | ||
---|---|---|---|
005 | 20250517151028.0 | ||
264 | 0 | _c20180404 | |
008 | 201804s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.16321 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSlobbe, Paul | |
245 | 0 | 0 |
_aDevelopment of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts. _h[electronic resource] |
260 |
_bOncotarget _cJun 2017 |
||
300 |
_a38337-38350 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarbon Radioisotopes _xpharmacokinetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aHeterografts |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xpharmacokinetics |
650 | 0 | 4 |
_aMelanoma _xdiagnostic imaging |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xgenetics |
650 | 0 | 4 | _aRadioactive Tracers |
650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
650 | 0 | 4 |
_aSulfonamides _xpharmacokinetics |
650 | 0 | 4 | _aTissue Distribution |
650 | 0 | 4 | _aVemurafenib |
700 | 1 | _aWindhorst, Albert D | |
700 | 1 | _aAdamzek, Kevin | |
700 | 1 | _aBolijn, Marije | |
700 | 1 | _aSchuit, Robert C | |
700 | 1 | _aHeideman, Daniƫlle A M | |
700 | 1 | _avan Dongen, Guus A M S | |
700 | 1 | _aPoot, Alex J | |
773 | 0 |
_tOncotarget _gvol. 8 _gno. 24 _gp. 38337-38350 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.16321 _zAvailable from publisher's website |
999 |
_c27090033 _d27090033 |